Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laure Dutrieux

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancers|August 7, 2021
Transcription/Replication Conflicts in Tumorigenesis and Their Potential Role as Novel Therapeutic Targets in Multiple MyelomaLaure Dutrieux, Yea-Lih Lin, Malik Lutzmann, et al.
Blood|April 21, 2024
Integrative single-cell chromatin and transcriptome analysis of human plasma cell differentiationElina Alaterre, Sara Ovejero, Caroline Bret, et al.
Frontiers in Oncology|December 21, 2023
Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myelomaAngélique Bruyer, Laure Dutrieux, Hugues de Boussac, et al.
Hematological Oncology|August 23, 2025
Synthetic Lethal Combinations of DNA Repair Inhibitors and Genotoxic Agents to Target High-Risk Diffuse Large B Cell LymphomaSara Ovejero, Julie Devin, Laura Alibert, et al.
Frontiers in Immunology|December 26, 2022
The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistanceSara Ovejero, Elena Viziteu, Laure Dutrieux, et al.
Blood Neoplasia|June 2, 2025
Targeting transcription-replication conflicts using G-quadruplexes stabilizers in multiple myelomaLaure Dutrieux, Sara Ovejero, Antoine Guillemin, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancers|August 7, 2021
Transcription/Replication Conflicts in Tumorigenesis and Their Potential Role as Novel Therapeutic Targets in Multiple MyelomaLaure Dutrieux, Yea-Lih Lin, Malik Lutzmann, et al.
Blood|April 21, 2024
Integrative single-cell chromatin and transcriptome analysis of human plasma cell differentiationElina Alaterre, Sara Ovejero, Caroline Bret, et al.
Frontiers in Oncology|December 21, 2023
Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myelomaAngélique Bruyer, Laure Dutrieux, Hugues de Boussac, et al.
Hematological Oncology|August 23, 2025
Synthetic Lethal Combinations of DNA Repair Inhibitors and Genotoxic Agents to Target High-Risk Diffuse Large B Cell LymphomaSara Ovejero, Julie Devin, Laura Alibert, et al.
Frontiers in Immunology|December 26, 2022
The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistanceSara Ovejero, Elena Viziteu, Laure Dutrieux, et al.
Blood Neoplasia|June 2, 2025
Targeting transcription-replication conflicts using G-quadruplexes stabilizers in multiple myelomaLaure Dutrieux, Sara Ovejero, Antoine Guillemin, et al.
Pageof 1